Minimum target prices for production of direct‐acting antivirals and associated diagnostics to combat hepatitis C virus

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|61|4|1174-1182

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.61, Iss.4, 2015-04, pp. : 1174-1182

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: direct‐acting antivirals significantly improve quality of life in patients with hepatitis C virus infection

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 4, 2018-02 ,pp. : 536-537

John Wiley & Sons Inc

Access to resources Recommend Favorite

Liver Fibrosis and Body Mass Index Predict Hepatocarcinogenesis following Eradication of Hepatitis C Virus RNA by Direct-Acting Antivirals

By  

Oncology, Vol. 91, Iss. 6, 2016-10 ,pp. : 341-347

Karger

Access to resources Recommend Favorite

Hepatitis C virus‐related symptoms, but not quality of life, were improved by treatment with direct‐acting antivirals

By  

HEPATOLOGY RESEARCH, Vol. 48, Iss. 3, 2018-02 ,pp. : E232-E239

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial: direct‐acting antivirals significantly improve quality of life in patients with hepatitis C virus infection—Author's reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 4, 2018-02 ,pp. : 537-538

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prednisolone does not affect direct‐acting antivirals against hepatitis C, but inhibits interferon‐alpha production by plasmacytoid dendritic cells

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 5, 2015-10 ,pp. : 707-715

John Wiley & Sons Inc

Access to resources Recommend Favorite